Location History:
- Cesson Sévigné, FR (2015)
- Cesson Sevigne, FR (2016)
Company Filing History:
2 out of 108 
2 out of 3,559 
1 out of 5,089 
Years Active: 2015-2016
Title: Innovator Franck Artzner: Pioneering Octapeptide Compounds
Introduction
Franck Artzner, hailing from Cesson Sevigné, France, is a notable inventor in the field of medicinal chemistry. With two patents to his name, his work focuses on the innovative development of octapeptide compounds that have significant potential in therapeutic applications.
Latest Patents
Artzner's latest patents delve into the realm of octapeptide compounds derived from somatostatin. His groundbreaking invention includes a novel class of octapeptide compounds with a general formula (I): H-2-Nal-cyclo(Cys-Tyr-AA-Lys-Val-Cys)-Thr-NH. These compounds exhibit strong affinity for specific somatostatin receptor subtypes, making them particularly advantageous in the treatment of various pathological conditions where somatostatin receptors play a crucial role. Additionally, these octapeptides possess favorable physiochemical properties that facilitate their use in diverse formulations for medicinal products, including pharmaceuticals equipped with acceptable carriers. His second patent similarly explores octapeptide compounds with a different structural framework: R-AA-cyclo(AA-Tyr-D-Trp-AA-Val-Cys)-Thr-NH. Both patents emphasize their significant roles in creating effective pharmaceutical compositions for various therapeutic uses.
Career Highlights
Franck Artzner has made substantial strides in his career, contributing significantly to fields requiring complex biochemical innovation. He has worked with leading organizations such as Ipsen Pharma S.A.S. and Commissariat à l'Énergie Atomique, where his expertise in peptide chemistry has proven invaluable.
Collaborations
Throughout his professional journey, Artzner has collaborated with distinguished colleagues, including Jean-Christophe Cintrat and Bernard Rousseau. These partnerships have fostered a collaborative environment, enhancing the potential for innovative breakthroughs in medicinal science.
Conclusion
Franck Artzner stands out as a prominent figure in the scientific community due to his contributions to the development of therapeutic octapeptide compounds. His patents not only pave the way for new treatments but also underscore the significance of collaborative efforts in the realm of innovation. As his inventions make strides towards improving healthcare, Artzner continues to exemplify the spirit of ingenuity in modern science.